Natural products from traditional Chinese medicine can be used as multi-targeted cancer therapies, which is a current trend in the treatment of NSCLC [11, 12], such as cordycepin’s anticancer effect interacting with and activating AMP-activated protein kinase (AMPK) [13], Emodin inhibited NSCLC proliferation by decreasing the expression of sPLA2-IIa and NF-κB pathways and suppressed mTOR and AKT and activated the AMPK pathway [14]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.